Vascular endothelium and hypovolemic shock

Current Vascular Pharmacology

Volumn 14, Issue 2, 2016, Pages 187-195

  Gulati, Anil ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Dengue; Ebola; Endothelin; Endothelium; Glycocalyx; Hemorrhagic shock; Nitric oxide; Syndecan; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; CASPASE 3; CASPASE 8; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; FORMYLPEPTIDE RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; NITRIC OXIDE; PROSTACYCLIN; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASOACTIVE AGENT;

ACIDOSIS; APOPTOSIS; ARTICLE; BLOOD CLOTTING DISORDER; CAPILLARY ENDOTHELIAL CELL; CELL MEMBRANE PERMEABILITY; DENGUE; EBOLA HEMORRHAGIC FEVER; HEMORRHAGIC SHOCK; HUMAN; HYPOTHERMIA; HYPOVOLEMIC SHOCK; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; RESUSCITATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE AGGREGATION; THROMBOSIS; VASCULAR ENDOTHELIUM; ANIMAL; METABOLISM; PATHOLOGY; PHYSIOLOGY; SHOCK;

ANIMALS; APOPTOSIS; ENDOTHELIUM, VASCULAR; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFLAMMATION; REACTIVE OXYGEN SPECIES; SHOCK;

EID: 84958951632     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161114666151202210221     Document Type: Article

References (153)

1. Jang DH, Nelson LS, Hoffman RS. Methylene blue for distributive shock: a potential new use of an old antidote. J Med Toxicol 2013; 9(3): 242-9.
2. Sawant DA, Tharakan B, Hunter FA, et al. The role of intrinsic apoptotic signaling in hemorrhagic shock-induced microvascular endothelial cell barrier dysfunction. J Cardiovasc Transl Res 2014; 7(8): 711-8.
3. Wu D, Dai H, Arias J, et al. Low-volume resuscitation from traumatic hemorrhagic shock with Na+/H+ exchanger inhibitor. Crit Care Med 2009; 37(6): 1994-9.
4. Shackford SR, Mackersie RC, Holbrook TL, et al. The epidemiology of traumatic death. A population-based analysis. Arch Surg 1993; 128(5): 571-5.
5. Acosta JA, Yang JC, Winchell RJ, et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998; 186(5): 528-33.
6. Bellamy RF. The causes of death in conventional land warfare: Implications for combat casualty care research. Mil Med 1984; 149(2): 55-62.
7. Hardy JF, de Moerloose P, Samama CM. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 2006; 53(6): S40-58.
8. Malone DL, Hess JR, Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 2006; 60(6): S91-6.
9. Ho AM, Karmakar MK, Contardi LH, et al. Excessive use of normal saline in managing traumatized patients in shock: A preventable contributor to acidosis. J Trauma 2001; 51(1): 173-7.
10. Ganster F, Burban M, de la Bourdonnaye M, et al. Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats. Crit Care 2010; 14(5): R165.
11. Hsia CJ, Ma L. A hemoglobin-based multifunctional therapeutic: Polynitroxylated pegylated hemoglobin. Artif Org 2012; 36(2): 215-20.
12. Zacharias N, Sailhamer EA, Li Y, et al. Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells. Resuscitation 2011; 82(1): 105-9.
13. Heslop DJ, Keay KA, Bandler R. Haemorrhage-evoked compensation and decompensation are mediated by distinct caudal midline medullary regions in the urethane-anaesthetised rat. Neuroscience 2002; 113(3): 555-67.
14. Liu LM, Ward JA, Dubick MA. Hemorrhage-induced vascular hyporeactivity to norepinephrine in select vasculatures of rats and the roles of nitric oxide and endothelin. Shock 2003; 19(3): 208-14.
15. Neligan PJ, Baranov D. Trauma and aggressive homeostasis management. Anesthesiol Clin 2013; 31(1): 21-39.
16. Alam HB, Rhee P. New developments in fluid resuscitation. Surg Clin North Am 2007; 87(1): 55-72.
17. Bickell WH, Bruttig SP, Millnamow GA, et al. The detrimental effects of intravenous crystalloid after aortotomy in swine. Surgery 1991; 110(3): 529-36.
18. Dubick MA, Bruttig SP, Wade CE. Issues of concern regarding the use of hypertonic/ hyperoncotic fluid resuscitation of hemorrhagic hypotension. Shock 2006; 25(4): 321-8.
19. Rhee P, Burris D, Kaufmann C, et al. Lactated Ringer's solution resuscitation causes neutrophil activation after hemorrhagic shock. J Trauma 1998; 44(2): 313-9.
20. Hahn RG. Fluid therapy in uncontrolled hemorrhage-what experimental models have taught us. Acta Anaesthesiol Scandinav 2013; 57(1): 16-28.
21. Johansson PI, Haase N, Perner A, et al. Association between sympathoadrenal activation, fibrinolysis, and endothelial damage in septic patients: A prospective study. J Crit Care 2014; 29(3): 327-33.
22. Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. J Trauma 2003; 54(6): 1127-30.
23. MacLeod J, Lynn M, McKenney MG, et al. Predictors of mortality in trauma patients. Am Surg 2004; 70(9): 805-10.
24. Schreiber MA, Perkins J, Kiraly L, et al. Early predictors of massive transfusion in combat casualties. J Am Coll Surg 2007; 205(4): 541-5.
25. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008; 64(5): 1211-7.
26. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: A review of mechanisms. J Trauma 2008; 65(4): 748-54.
27. Martini WZ. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma 2009; 67(1): 202-8.
28. Meng ZH, Wolberg AS, Monroe DM, 3rd, et al. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003; 55(5): 886-91.
29. Collins JA, Simmons RL, James PM, et al. The acid-base status of seriously wounded combat casualties. I. Before treatment. Ann Surg 1970; 171(4): 595-608.
30. Martini WZ, Pusateri AE, Uscilowicz JM, et al. Independent contributions of hypothermia and acidosis to coagulopathy in swine. J Trauma 2005; 58(5): 1002-10.
31. Martini WZ, Dubick MA, Pusateri AE, et al. Does bicarbonate correct coagulation function impaired by acidosis in swine? J Trauma 2006; 61(1): 99-106.
32. Martini WZ, Holcomb JB. Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg 2007; 246(5): 831-5.
33. Marumo M, Suehiro A, Kakishita E, et al. Extracellular pH affects platelet aggregation associated with modulation of store-operated Ca(2+) entry. Thromb Res 2001; 104(5): 353-60.
34. Engstrom M, Schott U, Romner B, et al. Acidosis impairs the coagulation: A thromboelastographic study. J Trauma 2006; 61(3): 624-8.
35. Watts DD, Trask A, Soeken K, et al. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 1998; 44(5): 846-54.
36. Arthurs Z, Cuadrado D, Beekley A, et al. The impact of hypothermia on trauma care at the 31st combat support hospital. Am J Surg 2006; 191(5): 610-4.
37. Wolberg AS, Meng ZH, Monroe DM, 3rd, et al. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 2004; 56(6): 1221-8.
38. Hess JR, Lawson JH. The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma 2006; 60(6): S12-9.
39. Kettner SC, Sitzwohl C, Zimpfer M, et al. The effect of graded hypothermia (36 degrees C-32 degrees C) on hemostasis in anesthetized patients without surgical trauma. Anesth Analg 2003; 96(6): 1772-6.
40. Zhang JN, Wood J, Bergeron AL, et al. Effects of low temperature on shear-induced platelet aggregation and activation. J Trauma 2004; 57(2): 216-23.
41. Wenceslau CF, McCarthy CG, Szasz T, et al. Mitochondrial damage-associated molecular patterns and vascular function. Eur Heart J 2014; 35(18): 1172-7.
42. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464(7285): 104-7.
43. Diebel LN, Liberati DM, Lucas CE, et al. Systemic not just mesenteric lymph causes neutrophil priming after hemorrhagic shock. J Trauma 2009; 66(6): 1625-31.
44. Ciesla DJ, Moore EE, Johnson JL, et al. The role of the lung in postinjury multiple organ failure. Surgery 2005; 138(4): 749-57.
45. Rhee P, Wang D, Ruff P, et al. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med 2000; 28(1): 74-8.
46. Meng ZH, Dyer K, Billiar TR, et al. Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock. Shock 2000; 14(1): 41-8.
47. Kobbe P, Schmidt J, Stoffels B, et al. IL-10 administration attenuates pulmonary neutrophil infiltration and alters pulmonary iNOS activation following hemorrhagic shock. Inflamm Res 2009; 58(3): 170-4.
48. Neidhardt R, Keel M, Steckholzer U, et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 1997; 42(5): 863-70.
49. Miller AC, Rashid RM, Elamin EM. The "T" in trauma: the helper T-cell response and the role of immunomodulation in trauma and burn patients. J Trauma 2007; 63(6): 1407-17.
50. Namas R, Ghuma A, Torres A, et al. An adequately robust early TNF-alpha response is a hallmark of survival following trauma/hemorrhage. PLoS One 2009; 4(12): e8406.
51. Makley AT, Goodman MD, Friend LA, et al. Resuscitation with fresh whole blood ameliorates the inflammatory response after hemorrhagic shock. J Trauma 2010; 68(2): 305-11.
52. Baron DM, Beloiartsev A, Nakagawa A, et al. Adverse effects of hemorrhagic shock resuscitation with stored blood are ameliorated by inhaled nitric oxide in lambs. Crit Care Med 2013; 41(11): 2492-501.
53. Wenceslau CF, McCarthy CG, Szasz T, et al. Mitochondrial Nformyl peptides induce cardiovascular collapse and sepsis-like syndrome. Amer J Physiol Heart Circul Physiol 2015; 308(7): H768-77.
54. Gill R, Tsung A, Billiar T. Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med 2010; 48(9): 1121-32.
55. Gallin JI. Degranulating stimuli decrease the neagative surface charge and increase the adhesiveness of human neutrophils. J Clin Investig 1980; 65(2): 298-306.
56. Weiss SJ. Tissue destruction by neutrophils. New Eng J Medic 1989; 320(6): 365-76.
57. Knaus WA, Draper EA, Wagner DP, et al. Prognosis in acute organ-system failure. Ann Surg 1985; 202(6): 685-93.
58. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992; 216(2): 117-34.
59. Motoyama T, Okamoto K, Kukita I, et al. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 2003; 31(4): 1048-52.
60. Mansfield KD, Simon MC, Keith B. Hypoxic reduction in cellular glutathione levels requires mitochondrial reactive oxygen species. J Appl Physiol 2004; 97(4): 1358-66.
61. Peralta C, Bulbena O, Xaus C, et al. Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation 2002; 73(8): 1203-11.
62. Bayir H, Kagan VE. Bench-to-bedside review: Mitochondrial injury, oxidative stress and apoptosis-there is nothing more practical than a good theory. Crit Care 2008; 12(1): 206.
63. Zheng W, Huang LZ, Zhao L, et al. Superoxide dismutase activity and malondialdehyde level in plasma and morphological evaluation of acute severe hemorrhagic shock in rats. Am J Emerg Med 2008; 26(1): 54-8.
64. Xu DQ, Gao C, Niu W, et al. Sodium hydrosulfide [lung inflammation and cell apoptosis following resuscitated hemorrhagic shock in rats. Acta Pharmacol Sinica 2013; 34(12): 1515-25.
65. Schlag G, Redl H. Morphology of the microvascular system in shock: Lung, liver, and skeletal muscles. Crit Care Med 1985; 13(12): 1045-9.
66. Mazzoni MC, Borgstrom P, Intaglietta M, et al. Lumenal narrowing and endothelial cell swelling in skeletal muscle capillaries during hemorrhagic shock. Circul Shock 1989; 29(1): 27-39.
67. Badonnel MC, DeGirolami U, Joris I, et al. The intracerebral microcirculation of the rat in hemorrhagic shock. J Neuropathol Experim Neurol 1983; 42(5): 561-78.
68. Higgs EA, Moncada S, Vane JR, et al. Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendothelium. Prostaglandins 1978; 16(1): 17-22.
69. Lefer AM, Ogletree ML, Smith JB, et al. Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science 1978; 200(4337): 52-4.
70. Moncada S, Gryglewski R, Bunting S, et al. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263(5579): 663-5.
71. Vane JR. The release and fate of vaso-active hormones in the circulation. Brit J Pharmacol 1969; 35(2): 209-42.
72. Ignarro LJ, Buga GM, Wood KS, et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proceed Nat Acad Sci USA 1987; 84(24): 9265-9.
73. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327(6122): 524-6.
74. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288(5789): 373-6.
75. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Investig 1986; 78(1): 1-5.
76. Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006; 25(34): 4798-811.
77. Hotchkiss RS, Strasser A, McDunn JE, et al. Cell death. New Eng J Med 2009; 361(16): 1570-83.
78. Childs EW, Tharakan B, Hunter FA, et al. Apoptotic signaling induces hyperpermeability following hemorrhagic shock. Amer J Physiol Heart Circul Physiol 2007; 292(6): H3179-89.
79. Childs EW, Udobi KF, Hunter FA, et al. Evidence of transcellular albumin transport after hemorrhagic shock. Shock 2005; 23(6): 565-70.
80. Dewar D, Moore FA, Moore EE, et al. Postinjury multiple organ failure. Injury 2009; 40(9): 912-8.
81. Roumen RM, Hendriks T, van der Ven-Jongekrijg J, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993; 218(6): 769-76.
82. Psaltis PJ, Harbuzariu A, Delacroix S, et al. Resident vascular progenitor cells-diverse origins, phenotype, and function. J Cardiovasc Transl Res 2011; 4(2): 161-76.
83. Schwartz SM, Benditt EP. Aortic endothelial cell replication. I. Effects of age and hypertension in the rat. Circ Res 1977; 41(2): 248-55.
84. Childs EW, Tharakan B, Byrge N, et al. Angiopoietin-1 inhibits intrinsic apoptotic signaling and vascular hyperpermeability following hemorrhagic shock. Amer J Physiol Heart Circul Physiol 2008; 294(5): H2285-95.
85. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277(5322): 55-60.
86. Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286(5449): 2511-4.
87. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGFdependent modulation of capillary structure and endothelial cell survival in vivo. Proceed Nat Acad Sci USA 2002; 99(17): 11205-10.
88. David S, Park JK, Meurs M, et al. Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis. Cytokine 2011; 55(2): 251-9.
89. Kim DH, Jung YJ, Lee AS, et al. COMP-angiopoietin-1 decreases lipopolysaccharide-induced acute kidney injury. Kidney Int 2009; 76(11): 1180-91.
90. Kumpers P, Gueler F, David S, et al. The synthetic tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit Care 2011; 15(5): R261.
91. Lipowsky HH. The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases. Ann Biomed Eng 2012; 40(4): 840-8.
92. Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflugers Archiv: Eur J Physiol 2000; 440(5): 653-66.
93. Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343(8901): 831-6.
94. Cruz MA, Handin RI, Wise RJ. The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein. J Biol Chem 1993; 268(28): 21238-45.
95. Handin RI, Wagner DD. Molecular and cellular biology of von Willebrand factor. Progr Hemost Thromb 1989; 9: 233-59.
96. van Mourik JA, Leeksma OC, Reinders JH, et al. Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from the platelet membrane glycoprotein IIa. J Biol Chem 1985; 260(20): 11300-6.
97. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006; 86(1): 279-367.
98. Vandenbroucke E, Mehta D, Minshall R, et al. Regulation of endothelial junctional permeability. Ann New York Acad Sci 2008; 1123: 134-45.
99. Hartsock A, Nelson WJ. Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton. Biochim et Biophys Acta 2008; 1778(3): 660-9.
100. Kanlaya R, Pattanakitsakul SN, Sinchaikul S, et al. Alterations in actin cytoskeletal assembly and junctional protein complexes in human endothelial cells induced by dengue virus infection and mimicry of leukocyte transendothelial migration. J Prot Res 2009; 8(5): 2551-62.
101. Lampugnani MG, Corada M, Caveda L, et al. The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with Vascular Endothelial cadherin (VE-cadherin). J Cell Biol 1995; 129(1): 203-17.
102. Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 2004; 84(3): 869-901.
103. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Molec Cell Biol 2004; 5(4): 261-70.
104. Alexander JS, Elrod JW. Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation. J Anatom 2002; 200(6): 561-74.
105. Michel CC, Curry FE. Microvascular permeability. Physiol Rev 1999; 79(3): 703-61.
106. Dejana E, Spagnuolo R, Bazzoni G. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 2001; 86(1): 308-15.
107. Luscinskas FW, Ma S, Nusrat A, et al. The role of endothelial cell lateral junctions during leukocyte trafficking. Immunol Rev 2002; 186: 57-67.
108. Kozar RA, Pati S. Syndecan-1 restitution by plasma after hemorrhagic shock. J Trauma Acute Care Surg 2015; 78(6): S83-6.
109. Reitsma S, Slaaf DW, Vink H, et al. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Archiv: Eur J Physiol 2007; 454(3): 345-59.
110. Torres Filho I, Torres LN, Sondeen JL, et al. In vivo evaluation of venular glycocalyx during hemorrhagic shock in rats using intravital microscopy. Microvasc Res 2013; 85: 128-33.
111. Minshall RD, Tiruppathi C, Vogel SM, et al. Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem Cell Biol 2002; 117(2): 105-12.
112. Schnittler HJ, Wilke A, Gress T, et al. Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endothelium. J Physiol 1990; 431: 379-401.
113. Vestweber D. Regulation of endothelial cell contacts during leukocyte extravasation. Curr Opin Cell Biol 2002; 14(5): 587-93.
114. Worthylake RA, Burridge K. Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Curr Opin Cell Biol 2001; 13(5): 569-77.
115. Mantovani A, Bussolino F, Introna M. Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol Today 1997; 18(5): 231-40.
116. Mutin M, Canavy I, Blann A, et al. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999; 93(9): 2951-8.
117. Mutunga M, Fulton B, Bullock R, et al. Circulating endothelial cells in patients with septic shock. Amer J Respir Crit Care Med 2001; 163(1): 195-200.
118. Solovey A, Lin Y, Browne P, et al. Circulating activated endothelial cells in sickle cell anemia. New Engl J Med 1997; 337(22): 1584-90.
119. George F, Poncelet P, Laurent JC, et al. Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody. J Immunol Meth 1991; 139(1): 65-75.
120. Yaghi A, Paterson NA, McCormack DG. Vascular reactivity in sepsis: Importance of controls and role of nitric oxide. Amer J Respir Crit Care Med 1995; 151(3 Pt 1): 706-12.
121. Rabiet MJ, Huet E, Boulay F. Human mitochondria-derived Nformylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur J Immunol 2005; 35(8): 2486-95.
122. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol 2002; 23(11): 541-8.
123. Gulati A, Srimal RC. Endothelin antagonizes the hypotension and potentiates the hypertension induced by clonidine. Eur J Pharmacol 1993; 230(3): 293-300.
124. Lavhale MS, Briyal S, Parikh N, et al. Endothelin modulates the cardiovascular effects of clonidine in the rat. Pharmacol Res 2010; 62(6): 489-99.
125. Sharma AC, Singh G, Gulati A. Decompensation characterized by decreased perfusion of the heart and brain during hemorrhagic shock: role of endothelin-1. J Trauma 2002; 53(3): 531-6.
126. Gulati A, Singh R, Chung SM, et al. Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats. J Lab Clin Med 1995; 126(6): 559-70.
127. Vincenzi R, Cepeda LA, Pirani WM, et al. Small volume resuscitation with 3% hypertonic saline solution decrease inflammatory response and attenuates end organ damage after controlled hemorrhagic shock. Am J Surg 2009; 198(3): 407-14.
128. Balogh Z, McKinley BA, Holcomb JB, et al. Both primary and secondary abdominal compartment syndrome can be predicted early and are harbingers of multiple organ failure. J Trauma 2003; 54(5): 848-59.
129. Bickell WH, Bruttig SP, Millnamow GA, et al. Use of hypertonic saline/dextran versus lactated Ringer's solution as a resuscitation fluid after uncontrolled aortic hemorrhage in anesthetized swine. Ann Emerg Med 1992; 21(9): 1077-85.
130. Chappell D, Bruegger D, Potzel J, et al. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care 2014; 18(5): 538.
131. Kumar R, Chakraborty I, Sehgal R. A prospective randomized study comparing two techniques of perioperative blood conservation: isovolemic hemodilution and hypervolemic hemodilution. Anesth Analg 2002; 95(5): 1154-61.
132. Rehm M, Haller M, Orth V, et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology 2001; 95(4): 849-56.
133. Bruegger D, Jacob M, Rehm M, et al. Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Amer J Physiol Heart Circul Physiol 2005; 289(5): H1993-9.
134. Bruegger D, Schwartz L, Chappell D, et al. Release of atrial natriuretic peptide precedes shedding of the endothelial glycocalyx equally in patients undergoing on-and off-pump coronary artery bypass surgery. Basic Res Cardiol 2011; 106(6): 1111-21.
135. Hierholzer C, Harbrecht B, Menezes JM, et al. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 1998; 187(6): 917-28.
136. Alam HB, Stanton K, Koustova E, et al. Effect of different resuscitation strategies on neutrophil activation in a swine model of hemorrhagic shock. Resuscitation 2004; 60(1): 91-9.
137. Ayuste EC, Chen H, Koustova E, et al. Hepatic and pulmonary apoptosis after hemorrhagic shock in swine can be reduced through modifications of conventional Ringer's solution. J Trauma 2006; 60(1): 52-63.
138. Rhee P, Koustova E, Alam HB. Searching for the optimal resuscitation method: recommendations for the initial fluid resuscitation of combat casualties. J Trauma 2003; 54(5 Suppl): S52-62.
139. Watters JM, Tieu BH, Todd SR, et al. Fluid resuscitation increases inflammatory gene transcription after traumatic injury. J Trauma 2006; 61(2): 300-8.
140. Santry HP, Alam HB. Fluid resuscitation: past, present, and the future. Shock 2010; 33(3): 229-41.
141. Morrison CA, Carrick MM, Norman MA, et al. Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock: preliminary results of a randomized controlled trial. J Trauma 2011; 70(3): 652-63.
142. Drabek T, Kochanek PM, Stezoski J, et al. Intravenous hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs. Shock 2011; 35(1): 67-73.
143. Dries DJ. Hypotensive resuscitation. Shock 1996; 6(5): 311-6.
144. Gulati A, Sen AP, Sharma AC, et al. Role of ET and NO in resuscitative effect of diaspirin cross-linked hemoglobin after hemorrhage in rat. Am J Physiol 1997; 273(2 Pt 2): H827-36.
145. Avirutnan P, Malasit P, Seliger B, et al. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 1998; 161(11): 6338-46.
146. Priyadarshini D, Gadia RR, Tripathy A, et al. Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One 2010; 5(1): e8709.
147. Bethell DB, Flobbe K, Cao XT, et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infectious Dis 1998; 177(3): 778-82.
148. Vasquez Ochoa M, Garcia Cordero J, Gutierrez Castaneda B, et al. A clinical isolate of dengue virus and its proteins induce apoptosis in HMEC-1 cells: a possible implication in pathogenesis. Arch Virol 2009; 154(6): 919-28.
149. Hensley LE, Geisbert TW. The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primates. Thrombos Haemost 2005; 94(2): 254-61.
150. Martinez O, Valmas C, Basler CF. Ebola virus-like particleinduced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain. Virology 2007; 364(2): 342-54.
151. Hutchinson KL, Rollin PE. Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J Infectious Dis 2007; 196(2): S357-63.
152. Sanchez A, Lukwiya M, Bausch D, et al. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 2004; 78(19): 10370-7.
153. McElroy AK, Erickson BR, Flietstra TD, et al. Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome. J Infectious Dis 2014; 210(4): 558-66.